Emphysema in an 11‐month‐old boy with alpha‐1 antitrypsin deficiency

Introduction: Alpha-1 antitrypsin deficiency (A1ATD) is characterized by reduced levels of protease inhibitor alpha-1 antitrypsin, most commonly manifesting with liver disease in childhood, and/or pulmonary disease starting in the 3rd decade of life. Childhood-onset lung disease in A1ATD has almost never been reported. Case presentation: An 11-month-old boy with a history of neonatal cholestasis and A1ATD phenotype PiZZ presented with prolonged fever of unknown origin. A computed tomography chest was obtained, given continued diagnostic uncertainty and the history of A1ATD, showing paramediastinal right upper lobe consolidation, as well as basilar centrilobular emphysema in the left lower lobe, likely secondary to the patient's A1ATD. The patient had no respiratory symptoms and clinically recovered with antibiotics. Conclusion: Pediatric development of emphysema has been rarely described, and this is the earliest documented case to date at 11 months of age. This is also the first finding of asymptomatic emphysema in childhood A1ATD, demonstrating that disease progression may be chronic and may transition from asymptomatic to symptomatic disease.

Authors

Institutions

Publication Details

Journal
Pediatric Investigation
Published
2026-07-30
DOI
https://doi.org/10.1002/ped4.70074
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emphysema in an 11‐month‐old boy with alpha‐1 antitrypsin deficiency

Leela Chandrasekar, Saif Al‐Qatarneh, Irvin Yi, Rachel Williams
Pediatric Investigation
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Emphysema in an 11‐month‐old boy with alpha‐1 antitrypsin deficiency

Leela Chandrasekar, Saif Al‐Qatarneh, Irvin Yi, Rachel Williams
article en

Abstract

Introduction: Alpha-1 antitrypsin deficiency (A1ATD) is characterized by reduced levels of protease inhibitor alpha-1 antitrypsin, most commonly manifesting with liver disease in childhood, and/or pulmonary disease starting in the 3rd decade of life. Childhood-onset lung disease in A1ATD has almost never been reported. Case presentation: An 11-month-old boy with a history of neonatal cholestasis and A1ATD phenotype PiZZ presented with prolonged fever of unknown origin. A computed tomography chest was obtained, given continued diagnostic uncertainty and the history of A1ATD, showing paramediastinal right upper lobe consolidation, as well as basilar centrilobular emphysema in the left lower lobe, likely secondary to the patient's A1ATD. The patient had no respiratory symptoms and clinically recovered with antibiotics. Conclusion: Pediatric development of emphysema has been rarely described, and this is the earliest documented case to date at 11 months of age. This is also the first finding of asymptomatic emphysema in childhood A1ATD, demonstrating that disease progression may be chronic and may transition from asymptomatic to symptomatic disease.

Pediatric Investigation
West Virginia University (US), Yale University (US)
Good health and well-being
Openalex Percentile: Top 10%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.